Mark Matson, Senior Director, Sensor Cloud at Medidata
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites,…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Frederico Braga, the Head of Digital and IT at Debiopharm, a Swiss…
Continue Reading
What You Should Know:
– Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.
– The strategic agreement will see…
Continue Reading
Drug-induced liver injury poses significant challenges in drug development and in clinical care. This study builds on prior work developing a Human Liver Virtual Twin by creating a Multiscale Computational Fluid Dynamics framework that…
Continue Reading
InSilicoTrials, a health tech company that develops AI-based simulation to predict drug safety and efficacy in the drug development process, announced it has been accepted into the Microsoft for Startups Pegasus Program. Microsoft for Startups…
Continue Reading
The Problem with Traditional Mental Health Assessment
Neuroscience technology company Brooklyn Health is leveraging artificial intelligence to address a critical flaw in neurology and psychiatry: the unreliable approach to mental health outcomes measurement. The startup’s…
What You Should Know:
– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story…
Continue Reading
Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…
Continue Reading
Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round, with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…
Continue Reading
Revolutionary Shift in Research Methodology
The National Institutes of Health (NIH) has announced a transformative program designed to expand innovative, human-based science while decreasing animal use in research. This landmark initiative acknowledges that while traditional…
